O
OrbiMed’s Janux Therapeutics JANX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28M | Buy |
1,210,300
+451,734
| +60% | +$10.4M | 0.7% | 38 |
|
2025
Q1 | $20.5M | Hold |
758,566
| – | – | 0.49% | 43 |
|
2024
Q4 | $40.6M | Sell |
758,566
-500,000
| -40% | -$26.8M | 0.84% | 35 |
|
2024
Q3 | $57.2M | Sell |
1,258,566
-1,721,262
| -58% | -$78.2M | 1.04% | 28 |
|
2024
Q2 | $125M | Sell |
2,979,828
-1,295,725
| -30% | -$54.3M | 2.46% | 10 |
|
2024
Q1 | $161M | Buy |
4,275,553
+957,626
| +29% | +$36.1M | 2.95% | 8 |
|
2023
Q4 | $35.6M | Hold |
3,317,927
| – | – | 0.71% | 50 |
|
2023
Q3 | $33.4M | Buy |
3,317,927
+481,541
| +17% | +$4.85M | 0.71% | 53 |
|
2023
Q2 | $33.7M | Hold |
2,836,386
| – | – | 0.61% | 52 |
|
2023
Q1 | $34.3M | Hold |
2,836,386
| – | – | 0.67% | 47 |
|
2022
Q4 | $37.4M | Hold |
2,836,386
| – | – | 0.71% | 51 |
|
2022
Q3 | $38.4K | Hold |
2,836,386
| – | – | 0.71% | 53 |
|
2022
Q2 | $34.6K | Hold |
2,836,386
| – | – | 0.63% | 50 |
|
2022
Q1 | $40.7M | Hold |
2,836,386
| – | – | 0.66% | 45 |
|
2021
Q4 | $56M | Sell |
2,836,386
-630,000
| -18% | -$12.4M | 0.72% | 46 |
|
2021
Q3 | $75M | Hold |
3,466,386
| – | – | 0.82% | 37 |
|
2021
Q2 | $86.5M | Buy |
+3,466,386
| New | +$86.5M | 0.87% | 37 |
|